Pfizer (PFE) Divestments (2012 - 2025)

Pfizer has disclosed Divestments across 6 years of filings, most recently posting -$6.3 billion for Q3 2025.

• In Q3 2025, Divestments fell 280.46% year-over-year to -$6.3 billion; the TTM figure through Dec 2025 stood at $6.3 billion (changed N/A YoY), while the FY2025 annual figure was $6.3 billion, down 10.36% from the prior year.
• Divestments eased to -$6.3 billion in Q3 2025, from $6.3 billion in the prior quarter.
• Over the last five years, Divestments for PFE reached as high as $6.3 billion in Q1 2025 and fell as low as -$6.3 billion in Q3 2025.
• The 4-year median for Divestments is $3.5 billion (2024), against an average of $2.5 billion.
• Annual changes were most pronounced in 2021 — Divestments surged 99.97% — and 2025, when it tumbled 280.46%.
• A 4-year view of Divestments shows it stood at -$3.0 million in 2021, then surged by 132100.0% to $4.0 billion in 2022, then retreated by 11.84% to $3.5 billion in 2024, then plunged by 280.46% to -$6.3 billion in 2025.
• According to Business Quant data, Divestments over the past three periods registered -$6.3 billion, $6.3 billion, and $6.3 billion for Q3 2025, Q2 2025, and Q1 2025 respectively.